Pharmacological treatment of obesity in adults in Norway 2004-2022.

Paz Lopez-Doriga RuizØystein KarlstadKjersti NøklebyKristina SlåtsveHanne L GulsethHaakon E MeyerKari Anne SveenElisabeth QvigstadKari Furu

Published in: Diabetes, obesity & metabolism (2024)

The use of anti-obesity drugs in Norway has increased substantially in recent years, especially among women aged 40 to 59 years. Changes in availability and reimbursement have influenced the use of these drugs in recent years.

Keyphrases

insulin resistance
metabolic syndrome
weight loss
type diabetes
weight gain
polycystic ovary syndrome
adipose tissue
pregnant women
body mass index
physical activity
drug induced